Pedestrians wearing protective masks, amid the coronavirus disease outbreak, make their way at Ginza shopping district which closed to cars on Sunday in Tokyo, Japan (Jan 10, 2021). - Reuters
TOKYO, Jan 10 (AP/Bloomberg): Japan’s government is considering approving Pfizer Inc.’s Covid-19 vaccine for use by individuals aged 16 years and above, broadcaster NHK reported.
Authorities will approve the vaccine for the age group as Japan’s clinical trials are conducted on people from 20 years old, so data on those younger isn’t unavailable, the report said, citing people familiar with the matter that it didn’t identify.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
